Suvretta Capital Management as of Dec. 31, 2021
Portfolio Holdings for Suvretta Capital Management
Suvretta Capital Management holds 95 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amazon (AMZN) | 7.0 | $360M | 108k | 3334.34 | |
| Microsoft Corporation (MSFT) | 5.6 | $291M | 865k | 336.32 | |
| UnitedHealth (UNH) | 4.4 | $229M | 457k | 502.14 | |
| Adobe Systems Incorporated (ADBE) | 4.3 | $222M | 392k | 567.06 | |
| Otis Worldwide Corp (OTIS) | 4.2 | $216M | 2.5M | 87.07 | |
| Union Pacific Corporation (UNP) | 3.9 | $204M | 808k | 251.93 | |
| Tapestry (TPR) | 3.6 | $185M | 4.5M | 40.60 | |
| Thermo Fisher Scientific (TMO) | 3.5 | $181M | 271k | 667.24 | |
| Gfl Environmental Sub Vtg Shs (GFL) | 3.4 | $175M | 4.6M | 37.85 | |
| Lauder Estee Cos Cl A (EL) | 3.2 | $166M | 449k | 370.20 | |
| AmerisourceBergen (COR) | 3.2 | $165M | 1.2M | 132.89 | |
| Iqvia Holdings (IQV) | 3.1 | $158M | 560k | 282.14 | |
| Analog Devices (ADI) | 2.8 | $144M | 819k | 175.77 | |
| Rh (RH) | 2.6 | $134M | 250k | 535.94 | |
| Quanta Services (PWR) | 2.6 | $133M | 1.2M | 114.66 | |
| Monster Beverage Corp (MNST) | 2.1 | $110M | 1.1M | 96.04 | |
| Carvana Cl A (CVNA) | 1.9 | $99M | 428k | 231.79 | |
| Hilton Worldwide Holdings (HLT) | 1.8 | $93M | 599k | 155.99 | |
| Opendoor Technologies (OPEN) | 1.7 | $90M | 6.2M | 14.61 | |
| Mastercard Incorporated Cl A (MA) | 1.7 | $90M | 250k | 359.32 | |
| Cano Health Com Cl A | 1.7 | $88M | 9.9M | 8.91 | |
| Alight Com Cl A (ALIT) | 1.6 | $84M | 7.8M | 10.81 | |
| Marriott Intl Cl A (MAR) | 1.6 | $82M | 494k | 165.24 | |
| Deckers Outdoor Corporation (DECK) | 1.5 | $79M | 216k | 366.31 | |
| Royalty Pharma Shs Class A (RPRX) | 1.5 | $78M | 2.0M | 39.85 | |
| Danaher Corporation (DHR) | 1.4 | $72M | 220k | 329.01 | |
| Block Cl A (SQ) | 1.3 | $69M | 430k | 161.51 | |
| Intra Cellular Therapies (ITCI) | 1.3 | $66M | 1.3M | 52.34 | |
| Te Connectivity SHS (TEL) | 1.2 | $62M | 383k | 161.34 | |
| Natera (NTRA) | 1.2 | $59M | 636k | 93.39 | |
| Mirati Therapeutics | 1.1 | $59M | 403k | 146.69 | |
| Rivian Automotive Com Cl A (RIVN) | 1.0 | $53M | 508k | 103.69 | |
| Kura Oncology (KURA) | 1.0 | $50M | 3.6M | 14.00 | |
| Copart (CPRT) | 0.9 | $46M | 305k | 151.62 | |
| Fulcrum Therapeutics (FULC) | 0.8 | $42M | 2.4M | 17.69 | |
| Ultragenyx Pharmaceutical (RARE) | 0.8 | $41M | 485k | 84.09 | |
| Agios Pharmaceuticals (AGIO) | 0.7 | $39M | 1.2M | 32.87 | |
| Sutro Biopharma (STRO) | 0.7 | $36M | 2.4M | 14.88 | |
| Warby Parker Cl A Com (WRBY) | 0.7 | $34M | 733k | 46.56 | |
| KBR (KBR) | 0.6 | $33M | 686k | 47.62 | |
| Marinus Pharmaceuticals Com New (MRNS) | 0.6 | $31M | 2.6M | 11.88 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.6 | $31M | 2.5M | 12.24 | |
| Insmed Com Par $.01 (INSM) | 0.6 | $30M | 1.1M | 27.24 | |
| Etsy (ETSY) | 0.5 | $27M | 122k | 218.94 | |
| Marqeta Class A Com (MQ) | 0.5 | $25M | 1.5M | 17.17 | |
| Kezar Life Sciences (KZR) | 0.5 | $24M | 1.4M | 16.72 | |
| Kalvista Pharmaceuticals (KALV) | 0.4 | $23M | 1.7M | 13.23 | |
| Arena Pharmaceuticals Com New | 0.4 | $23M | 246k | 92.94 | |
| Heron Therapeutics (HRTX) | 0.4 | $23M | 2.5M | 9.13 | |
| Xenon Pharmaceuticals (XENE) | 0.4 | $22M | 692k | 31.24 | |
| Chinook Therapeutics | 0.4 | $20M | 1.2M | 16.31 | |
| Coherus Biosciences (CHRS) | 0.4 | $20M | 1.2M | 15.96 | |
| Chimerix (CMRX) | 0.3 | $18M | 2.8M | 6.43 | |
| Inflarx Nv (IFRX) | 0.3 | $16M | 3.3M | 4.76 | |
| Point Biopharma Global | 0.3 | $15M | 2.7M | 5.60 | |
| Mereo Biopharma Group Ads (MREO) | 0.3 | $15M | 9.1M | 1.60 | |
| Grab Holdings Class A Ord (GRAB) | 0.3 | $14M | 2.0M | 7.13 | |
| Aeglea Biotherapeutics | 0.2 | $12M | 2.6M | 4.75 | |
| Pharvaris N V (PHVS) | 0.2 | $12M | 828k | 14.39 | |
| Solid Biosciences | 0.2 | $11M | 6.3M | 1.75 | |
| Bolt Biotherapeutics (BOLT) | 0.2 | $11M | 2.2M | 4.90 | |
| Dice Therapeutics | 0.2 | $10M | 410k | 25.31 | |
| Ambrx Biopharma Sponsored Ads | 0.2 | $9.6M | 1.1M | 9.03 | |
| Terns Pharmaceuticals (TERN) | 0.2 | $8.8M | 1.2M | 7.07 | |
| Molecular Partners Ads (MOLN) | 0.1 | $7.7M | 400k | 19.18 | |
| Sio Gene Therapies Common | 0.1 | $7.6M | 5.9M | 1.29 | |
| Inozyme Pharma (INZY) | 0.1 | $6.9M | 1.0M | 6.82 | |
| Gemini Therapeutics | 0.1 | $6.9M | 2.4M | 2.91 | |
| Roivant Sciences SHS (ROIV) | 0.1 | $6.9M | 682k | 10.08 | |
| Oric Pharmaceuticals (ORIC) | 0.1 | $6.5M | 441k | 14.70 | |
| Milestone Pharmaceuticals (MIST) | 0.1 | $5.6M | 851k | 6.55 | |
| Otonomy | 0.1 | $5.6M | 2.7M | 2.08 | |
| Abcellera Biologics Call Option (ABCL) | 0.1 | $5.3M | 367k | 14.30 | |
| Research Alliance Corp Ii Com Cl A | 0.1 | $4.9M | 500k | 9.77 | |
| Allogene Therapeutics (ALLO) | 0.1 | $4.0M | 265k | 14.92 | |
| Nuvalent Inc-a (NUVL) | 0.1 | $3.8M | 200k | 19.04 | |
| Immuneering Corp Class A Com (IMRX) | 0.1 | $3.2M | 200k | 16.17 | |
| Omega Alpha Spac Cl A | 0.1 | $2.9M | 300k | 9.77 | |
| European Biotech Acqutn Corp Class A Ord Shs | 0.1 | $2.9M | 300k | 9.69 | |
| Benitec Biopharma | 0.0 | $2.0M | 769k | 2.62 | |
| Opy Acquisition Corp I Unit 09/22/2026 | 0.0 | $2.0M | 200k | 10.00 | |
| Turmeric Acquisition Corp Cl A | 0.0 | $2.0M | 200k | 9.82 | |
| Bcls Acquisition Corp Com Cl A | 0.0 | $2.0M | 200k | 9.80 | |
| Entrada Therapeutics (TRDA) | 0.0 | $1.8M | 106k | 17.12 | |
| Cano Health *w Exp 06/03/202 (CANWQ) | 0.0 | $1.6M | 675k | 2.39 | |
| Decibel Therapeutics | 0.0 | $1.2M | 264k | 4.65 | |
| Eucrates Biomedical Acqu Cor SHS | 0.0 | $976k | 100k | 9.76 | |
| Frazier Lifesciences Acqu Cl A Shs | 0.0 | $853k | 88k | 9.75 | |
| Meiragtx Holdings (MGTX) | 0.0 | $821k | 35k | 23.73 | |
| Sorrento Therapeutics Com New (SRNEQ) | 0.0 | $492k | 106k | 4.65 | |
| Finserv Acquisition Corp Ii *w Exp 02/17/202 | 0.0 | $169k | 273k | 0.62 | |
| European Biotech Acqutn Corp *w Exp 03/06/202 | 0.0 | $60k | 100k | 0.60 | |
| Turmeric Acquisition Corp *w Exp 10/08/202 | 0.0 | $45k | 67k | 0.68 | |
| Eucrates Biomedical Acqu Cor *w Exp 10/23/202 | 0.0 | $19k | 33k | 0.57 | |
| Frazier Lifesciences Acqu *w Exp 11/30/202 | 0.0 | $17k | 29k | 0.58 |
